Abstract PS6-63: Validation of CTS5 as a predictor of distant late recurrence risk in HER2 negative luminal breast cancer: Latin American experience
Vian, Lucas, Souza, Ronaldo, Lima, Vladmir C. C., Honda, Daniella Y. T., Pacheco, Samara T., Liz, Caio D., Gomes, Luciana B.M., Júnior, Bruno C. M. U., Guimarães, Paula T., Filho, Celso S. S., Guimarães, Andréa P., Donadio, Mauro D. S., Fêde, Angelo B.S., Saito, Augusto O., Ribeiro, Adriana R.G., Maia, Joyce M. L., Lustosa, Iara K. F., Castro, Fabricio S., Tavares, Monique C., Cesca, Marcelle G., Corassa, Marcelo, Pondé, Noam F., Sanches, Solange
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article